« Back
Home /
Canertinib dihydrochloride

Canertinib dihydrochloride

Manufacturer	TargetMol
Category	Oncology Neuroscience Neural Signaling Reagents & Chemicals Molecules By Organ Bladder Cancer
Type	Molecules
Specific against	other
Amount	10mM*1mL(inDMSO)
Item no.	TMO-T2501-10mM
CASRN	289499-45-2
eClass 6.1	32169090
eClass 9.0	32169090
Available
Description	Canertinib Dihydrochloride is the hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities. Canertinib binds to the intracellular domains of epidermal growth factor receptor tyrosine kinases (ErbB family), irreversibly inhibiting their signal transduction functions and resulting in tumor cell apoptosis and suppression of tumor cell proliferation. This agent also acts as a radiosensitizing agent and displays synergistic activity with other chemotherapeutic agents.
Formulate	C24H27Cl3FN5O3
Shipping temperature	Cool Pack
Smeles	FC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4) =C(NC(=O)C=C)C=C23)C=C1
Storage Temperature	-20C
Target's name	EGFR inhibitor, HER2 inhibitor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mM*1mL(inDMSO)

available

Delivery expected until 5/23/2024